General Statement of Beneficial Ownership — Schedule 13D Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: SC 13D Adeona Pharmaceuticals Inc Schedule 13D 12-7-2011 HTML 79K
2: EX-4 Instrument Defining the Rights of Security Holders HTML 8K
EX-4 — Instrument Defining the Rights of Security Holders
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Adeona Pharmaceuticals, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 12th day of December, 2011.